Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels – a study in twins

[1]  M. Neurath,et al.  A Genetic Basis for IFN-γ Production and T-bet Expression in Humans1 , 2005, The Journal of Immunology.

[2]  E. Benjamin,et al.  Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q. , 2005, Atherosclerosis.

[3]  D. Posthuma,et al.  Human Cytokine Response to ex vivo Amyloid-β Stimulation is Mediated by Genetic Factors , 2005, Twin Research and Human Genetics.

[4]  D. Posthuma,et al.  Heritability estimates of innate immunity: an extended twin study , 2005, Genes and Immunity.

[5]  B. Howard,et al.  Genetic Determination of Acute Phase Reactant Levels: The Strong Heart Study , 2005, Human Heredity.

[6]  L. Khaodhiar,et al.  Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. , 2004, JPEN. Journal of parenteral and enteral nutrition.

[7]  K. Christensen,et al.  Genetic Influence on Inflammation Variables in the Elderly , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[8]  G. Latkovskis,et al.  C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. , 2004, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[9]  S. Devaraj,et al.  C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis? , 2004, Hypertension.

[10]  Tim D. Spector,et al.  Obesity Is an Important Determinant of Baseline Serum C-Reactive Protein Concentration in Monozygotic Twins, Independent of Genetic Influences , 2004, Circulation.

[11]  U. Maggiore,et al.  Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  P. Talmud,et al.  Heritability of multivariate factors of the metabolic syndrome in nondiabetic Japanese americans. , 2004, Diabetes.

[13]  S. Rubin,et al.  Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study , 2003, Circulation.

[14]  M. Puato,et al.  C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? , 2003, Journal of hypertension.

[15]  L. Retterstøl,et al.  A twin study of C-Reactive Protein compared to other risk factors for coronary heart disease. , 2003, Atherosclerosis.

[16]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[17]  C. Freitag,et al.  Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins , 2002, The Lancet.

[18]  J. Manson,et al.  Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. , 2002, JAMA.

[19]  E. Kobyliansky,et al.  Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population. , 2002, Cytokine.

[20]  M. Lathrop,et al.  Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. , 2002, Cardiovascular research.

[21]  R. Marfella,et al.  Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year , 2002, Circulation.

[22]  E. Poehlman,et al.  Weight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women , 2002, Circulation.

[23]  M. Nunn,et al.  C-reactive protein levels are influenced by common IL-1 gene variations. , 2002, Cytokine.

[24]  A. Siegbahn,et al.  Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. , 2001, JAMA.

[25]  J. Pankow,et al.  Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. , 2001, Atherosclerosis.

[26]  S. Humphries,et al.  Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. , 2000, European heart journal.

[27]  G. Lowe,et al.  Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. , 2000, Clinical chemistry.

[28]  P. Ridker,et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.

[29]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[30]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[31]  J. Pankow,et al.  Acute-phase Inflammatory Response to Periodontal Disease in the US Population , 2000, Journal of dental research.

[32]  M. Pepys,et al.  C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction , 1999, The Journal of experimental medicine.

[33]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[34]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[35]  E. Barrett-Connor,et al.  Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. , 1999, Circulation.

[36]  M. Pfeffer,et al.  Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein , 1999 .

[37]  C. Visser,et al.  C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? , 1999, Circulation.

[38]  J. Danesh,et al.  Risk factors for coronary heart disease and acute-phase proteins. A population-based study. , 1999, European heart journal.

[39]  P. Garcia-Lorda,et al.  Tumour necrosis factor, a key role in obesity? , 1999, FEBS letters.

[40]  H. Cohen,et al.  Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.

[41]  E. Bruckert,et al.  Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. , 1999, Circulation.

[42]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[43]  L. Kuller,et al.  Hormone replacement therapy, inflammation, and hemostasis in elderly women. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[44]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[45]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[46]  R. Westendorp,et al.  Determination of tumour necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation. , 1998, Journal of immunological methods.

[47]  R Peto,et al.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.

[48]  P. Ridker,et al.  Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. , 1998, Circulation.

[49]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[50]  L. Kuller,et al.  Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[51]  M. Neale,et al.  Genetic and Environmental Factors in Relative Body Weight and Human Adiposity , 1997, Behavior genetics.

[52]  T. Huizinga,et al.  Genetic influence on cytokine production in meningococcal disease , 1997, The Lancet.

[53]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[54]  G. Ciliberto,et al.  Elevated levels of interleukin-6 in unstable angina. , 1996, Circulation.

[55]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[56]  R. Simsolo,et al.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.

[57]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[58]  B. Klein,et al.  C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. , 1992, Arthritis and rheumatism.

[59]  U. Ikeda,et al.  Serum interleukin 6 levels become elevated in acute myocardial infarction. , 1992, Journal of molecular and cellular cardiology.

[60]  J V Castell,et al.  Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.

[61]  A. Stunkard,et al.  A twin study of human obesity. , 1986, JAMA.

[62]  F. Vogel,et al.  Human Genetics: Problems and Approaches , 1979 .

[63]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[64]  Hisashi Adachi,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[65]  M. Neurath,et al.  A genetic basis for IFN-gamma production and T-bet expression in humans. , 2005, Journal of immunology.

[66]  T. Spector,et al.  Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. , 2004, Clinical chemistry.

[67]  S. Humphries,et al.  Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. , 2003, The Journal of clinical endocrinology and metabolism.

[68]  M. Pfeffer,et al.  Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. , 1999, Circulation.

[69]  S. Akira,et al.  Interleukin-6 in biology and medicine. , 1993, Advances in immunology.

[70]  J. Vilček,et al.  Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. , 1989, Laboratory investigation; a journal of technical methods and pathology.